You are here: Industry Insights > US

News List

Novartis secures US rights to Adamis' epinephrine auto injector pharmafile
July 06, 2018
Under the agreement, the Swiss pharma firm will be awarded the rights to the 0.3mg and 0.15mg dosages of the product, subject to FDA approval.
US scientists to develop rapid diagnostic test for Zika fiercepharma
July 02, 2018
The team has developed tiny platinum nanomotors that target Zika as well as microbeads that bind the virus.
Zydus Cadila gets US FDA nod for erectile dysfunction drug financialexpress
June 29, 2018
Drug firm Zydus Cadila has received approval from the US health regulator to market Tadalafil tablets, used to erectile dysfunction, in the American market.
Cipla gets US FDA approval for Generic Sustiva financialexpress
June 29, 2018
Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Efavirenz Tablets 600mg from the United States Food and Drug Administration (US FDA).
Lupin aims to launch around 30 generic products in the US financialexpress
June 29, 2018
With rapid approvals from US health regulator anticipated, homegrown drug major Lupin sees opportunity to launch around 30 generic products in the world’s largest pharmaceuticals market this year, according to a top company official.
Aurobindo Pharma’s generic Ertapenem Injection bags US FDA approval financialexpress
June 29, 2018
Ertapenem injection is used for the treatment of moderate to severe infections caused by susceptible bacteria
Dr Reddy's just-approved opioid dependence generic blocked over US patent dispute pharmafile
June 22, 2018
Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) secured FDA approval for the treatment of opioid dependence,
Keytruda approved for second blood cancer pharmatimes
June 21, 2018
US regulators have again expanded the list of approved uses of MSD’s immunotherapy Keytruda, issuing a green light for the treatment of primary mediastinal large B-cell lymphoma (PMBCL).
US approves joint damage data for Cosentyx pharmatimes
June 21, 2018
US regulators have approved new evidence showing that Novartis’ Cosentyx significantly slows progression of joint structural damage in patients with active psoriatic arthritis (PsA).
Roche snaps up rest of Foundation Medicine for $2.4bn pharmatimes
June 21, 2018
Roche is buying the shares it does not already own in US molecular information company Foundation Medicine (FMI), in a deal valued at $2.4 billion.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page